Mesoblast Ltd. (MESO) financials: revenue, earnings and cash flow
Fiscal 2016–2025 · from SEC filings · data as of November 13, 2026
Summary
Mesoblast’s revenue went from $43M in fiscal 2016 to $17M in fiscal 2025, a decline of about 9.6% a year.
Net income in fiscal 2025 was -$102M, a net margin of -593.9%; the best year in this period was 2016 with -$4M.
Free cash flow was -$51M in fiscal 2025 and positive in 0 of the 10 years shown.
Revenue, profit and cash flow by year
Income statement
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | $6M | $8M | $10M | $7M | $32M | $17M | $17M | $2M | $43M |
| Gross profit | $12M | $6M | $8M | — | — | — | — | — | — | — |
| Operating income | -$80M | -$67M | -$63M | — | — | — | — | — | — | — |
| Net income | -$102M | -$88M | -$82M | -$91M | -$99M | -$78M | -$90M | -$35M | -$77M | -$4M |
| EPS (diluted) | $-0.79 | $-0.68 | $-0.63 | $-0.70 | $-0.76 | $-0.60 | $-0.69 | $-0.27 | $-0.59 | $-0.03 |
| R&D | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | +191.4% | −21.3% | −26.5% | +37.4% | −76.9% | +92.3% | −3.6% | +618.9% | −94.3% | — |
Cash flow
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$50M | -$48M | -$63M | -$66M | -$101M | -$50M | -$58M | -$75M | -$95M | -$88M |
| Capital spending | -$680000 | -$271000 | -$264000 | — | — | — | — | — | — | — |
| Free cash flow | -$51M | -$49M | -$64M | — | — | — | — | — | — | — |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $22M | $6M | $4M | $6M | $13M | $8M | $4M | $6M | $5M | $3M |
Balance sheet
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | $162M | $63M | $71M | $60M | $137M | $129M | $50M | $38M | $46M | $81M |
| Debt | $122M | $114M | $109M | $97M | $94M | $89M | $81M | $59M | $0 | — |
| Equity | $597M | $480M | $502M | $497M | $581M | $549M | $481M | $546M | $517M | $528M |
| Total assets | $785M | $669M | $669M | $662M | $745M | $734M | $652M | $692M | $656M | — |
| Shares (diluted) | 130M | 130M | 130M | 130M | 130M | 130M | 130M | 130M | 130M | 130M |
Margins and returns
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 70.2% | 100.0% | 100.0% | — | — | — | — | — | — | — |
| Operating margin | -465.5% | -1143.5% | -835.3% | — | — | — | — | — | — | — |
| Net margin | -593.9% | -1490.3% | -1091.7% | -894.6% | -1329.2% | -242.4% | -537.0% | -203.5% | -3184.7% | -9.7% |
| FCF margin | -294.4% | -825.6% | -847.0% | — | — | — | — | — | — | — |
| ROIC | -8.8% | -11.3% | -10.2% | — | — | — | — | — | — | — |
| ROE | -17.1% | -18.3% | -16.3% | -18.4% | -17.0% | -14.2% | -18.7% | -6.5% | -14.9% | -0.8% |
Frequently asked questions
What is Mesoblast’s annual revenue?
$17M in fiscal 2025.
How much profit does Mesoblast make?
Net income was -$102M in fiscal 2025 (net margin -593.9%).
Is Mesoblast’s revenue growing?
Yes: revenue rose 191.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.